Group purchasing organization Novation awarded new cardiovascular contracts to a host of market leaders, effective at the beginning of 2013.
Marine Polymer Technologies Inc.
HemCon Medical Technologies said it’s filing for Chapter 11 bankruptcy protection for its U.S. operation after losing a $34.2 million court decision last month, saying it plans to appeal the ruling.
In March a sharply split U.S. Court of Appeals for the Federal Circuit reversed course and reinstated a win for Marine Polymer Technologies in its wound dressing patent spat with HemCon.
A sharply split federal appeals court reversed course and reinstated a $29.4 million win for Marine Polymer Technologies in its wound dressing patent spat with HemCon Medical Technologies.
The U.S. Court of Appeals for the Federal Circuit, in an en banc decision joined in full by 5 of 9 judges on the panel, ruled that the "intervening rights" of a company accused of patent infringement are only valid when patent claim language is changed during re-examination.
A trio of med-tech titans logged a win against Johnson & Johnson (NYSE:JNJ) in a long-running battle over drug-eluting coronary stent patents.
A patent spat between St. Jude Medical (NYSE:STJ) and Occlutech GmbH that morphed into a personal lawsuit against Occlutech CEO Tor Peters was dismissed by a German court, prompting Peters to call the suit "amazing and quite shocking."
St. Jude inherited the case, involving intravascular occlusion devices, after it acquired AGA Medical for more than $1 billion last year.
U.S. Court of Appeals for the Federal Circuit granted HemCon Medical Technologies Inc. the right to continue selling its hemostatic bandages by staying an injunction against the company.
The appeals court ruling also postponed the damages payment that the Portland, Ore.-based company was ordered to pay in an ongoing patent infringement lawsuit brought by Marine Polymer Technologies Inc. in 2006 over bio-compatible polymers used in its hemostatic products.
Marine Polymer Technologies Inc. added a notch to its belt in a long-running patent spat against HemCon Medical Technologies Inc. over bio-compatible polymers used to make hemostatic bandages.
Danvers, Mass.-based Marine Polymer won an injunction from the U.S. District Court for New Hampshire, barring HemCon from selling its HemCon bandage, ChitoFlex dressing and HemCon dental dressing "and any other products which are no more than colorably different from these infringing products," for as long as the patent is in effect, according to court documents.
A federal jury handed Marine Polymer Technologies Inc. a $29.4 million verdict in a four-year-old patent infringement lawsuit against HemCon Medical Technologies Inc. over bio-compatible polymers used to make hemostatic bandages.